A shifting market environment and strategies fueling innovation in prostate cancer treatment
Nat Biotechnol
.
2025 Apr;43(4):487-490.
doi: 10.1038/s41587-025-02617-9.
Authors
Michael Casasanta
1
,
Nicholas Frame
2
,
Oded Ben-Joseph
2
Affiliations
1
Outcome Capital LLC, Boston, MA, USA. mcasasanta@outcomecapital.com.
2
Outcome Capital LLC, Boston, MA, USA.
PMID:
40229363
DOI:
10.1038/s41587-025-02617-9
No abstract available